FEATURED POST
What You Can Learn from 7 Theme Fusion Success Stories
Nam lacinia arcu tortor, nec luctus nibh dignissim eu. Nulla sit amet maximus nulla. Pellentesque a accumsan eros, ac molestie nulla. Morbi interdum in neque vitae vulputate.
CVBF’s Expertise in Phase I Clinical Trials: A Commitment to Excellence
Phase 1 trials, be they conducted on healthy volunteers or patients, focus on generation of initial knowledge on tolerability, safety and PK/PD.. [...]
Unveiling the New and Improved Website
In today's fast-paced digital world, a company's online presence is often its first point of contact with customers. It's not just a [...]
A short history of CVBF
We are thrilled to invite you to watch the CVBF History Timeline Video to have a glimpse of our journey through the [...]
CVBF participates in the Smarter Programme For Technological Innovation
Thanks to the close collaboration with Aldo Moro University of Bari, Exprivia spa and Hero srl, and following the agreement signed [...]
CVBF September Special Issue
This new Special Issue is dedicated to the active involvement of CVBF in the European Joint Programme for Rare Diseases [...]
Scientific publication: Patient-Reported Outcome Measures in Clinical Research
The “Patient-Reported Outcome Measures in Clinical Research” research paper describes the importance and also some limitations of the use of [...]
European Research and Innovation Days 2022
The European Research and Innovation Days will take place online on 28 and 29 September 2022, allowing everyone to get [...]
II Level Master in Preclinical and Clinical Research
The University of Parma will organise the II Level Master in Preclinical and Clinical Research for the Academic Year 2020/2021. The courses will start in [...]
Webinar: Paediatric diseases: research, biodrugs and territory
The Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies (IBIOM) of the National Research Council (CNR) in collaboration with the Consorzio per Valutazioni Biologiche e Farmacologiche [...]
Newsletter, AUGUST 2020
18th August 2020 Newsletter August 2020 EPTRI Stakeholders Roundtable was held on July: what are the future strategies of the paediatric research? On 9 July [...]
CVBF answered to the Public Consultation: Pharmaceuticals – safe and affordable medicines (new EU strategy)
The European Commission is launching a new strategy to improve and accelerate patients’ access to safe and affordable medicines and to support innovation in the [...]
CVBF is involved with the University of Pittsburgh in developing two vaccines for the coronavirus disease
We are glad to inform you that Consorzio per Valutazioni Biologiche e Farmacologiche will provide its contribution in the fight against COVID-19 emergency. It was [...]
COVID-19: EMA sets up infrastructure for real-world monitoring of treatments and vaccines
EMA has now set up an infrastructure to support the monitoring of the efficacy and safety of COVID-19 treatments and vaccines when used in day-to-day [...]









